ReviewClinical hypertension2026
To be (IIb), or not to be (IIb) - That is the current status of cuffless blood pressure monitoring device.
Review in Clinical hypertension, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Cuffless blood pressure (BP) monitoring devices have attracted extraordinary scientific and commercial attention, yet their clinical status remains deeply contested. Major international guidelines from the American Heart Association/American College of Cardiology (2025), the European Society of Cardiology (2024), and the European Society of Hypertension (ESH, 2023) uniformly assign a Class III recommendation (not recommended for diagnostic use) to cuffless devices due to insufficient validation and calibration drift. However, the Korean Society of Hypertension has recently updated its guidelines to include cuffless BP monitors as a Class IIb recommendation for out-of-office BP measurement. This review explores the rationale behind this divergence, largely based on the acclumulating validation of a domestic ring-type cuffless device, CART BP (Sky Labs), currently the world's only nationally insured cuffless monitor. We analyze the historical landscape of international validation, detail the sequential fulfillment of ESH criteria, and delineate future research imperatives-emphasizing calibration practicality, transient BP changes, and cardiovascular outcome validation-to pave the way for universal clinical adoption.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.